Lp(a), PREVENT, and LDL-C Goals: Insights From NLA Fall Update
Share
Subscribe
Recorded at the National Lipid Association (NLA) meeting in Orlando, Florida, in partnership with the NLA's Lipid Insights podcast, this episode of the Tell-Tale Heart features host Craig Beavers, PharmD, in conversation with lipidologist Michael J. Wilkinson, MD, FACC, FNLA. They discuss how the 2026 ACC/AHA multisociety dyslipidemia guideline is changing practice, why Lp(a) testing remains important after the topline Lp(a)HORIZON results, and how clinicians and pharmacists can personalize lipid-lowering therapy.
This was a collaboration with the National Lipid Association's Lipid Insights podcast. You can listen to more Lipid Insights on Apple Podcasts or Spotify.
Michael J. Wilkinson, MD, FACC, FNLA, is an associate professor of medicine and director of the advanced lipid treatment program at UC San Diego Health. You can find him on Linkedin.